Case report describes insulin autoimmune syndrome

May 7, 2017

(HealthDay)—In a case report published online May 1 in Diabetes Care, resolution of hypoglycemia and cardiovascular dysfunction after rituximab treatment of insulin autoimmune syndrome is described.

David Church, from the University of Cambridge Metabolic Research Laboratories in the United Kingdom, and colleagues report on the case of a 37-year-old female who presented to the emergency department after having collapsed. She had reported recurrent dizziness since the birth of her fifth child, and when symptomatic had recorded low capillary blood glucose. During her most recent pregnancy she had gestational diabetes, which was treated with insulin aspart, , and metformin.

The authors note that the patient had early-morning and postprandial hyperglycemia. The patient had high circulating insulin during hypoglycemia. An insulin assay was performed and serum anti-insulin immunoglobulin G concentration was 171 mg/L; insulin autoimmune syndrome was diagnosed. The patient was fitted with continuous glucose monitoring (CGM) with a hypoglycemia alarm, and was prescribed frequent low-glycemic index carbohydrate meals. Prednisone was commenced as significant hypoglycemia continued, and rituximab was given to reduce anti-insulin antibodies. After six weeks, repeat CGM demonstrated intermittent hypoglycemia and sustained daytime hyperglycemia. There were reductions in total insulin, anti-insulin antibody concentration, and antibody-bound insulin over the following months. Hypoglycemia was rare and postprandial hyperglycemia had improved by six months.

"We show that B-cell depletion with rituximab induces a sustained reduction in anti-insulin antibodies, circulating , and the frequency of hypoglycemia," the authors write.

Explore further: Risks of diabetics fasting during Ramadan: Hypoglycemia rates with insulin pump v. injections

More information: Abstract
Full Text

Related Stories

Lowest glucose variability for insulin + GLP-1 RA in T2DM

December 20, 2016

(HealthDay)—For patients with type 2 diabetes, the lowest glucose variability (GV) and hypoglycemia is seen for patients using basal insulin + glucagon-like peptide 1 receptor agonist (GLP-1 RA) (BGLP), according to a study ...

Premixed insulin ups hypoglycemia in inpatients

October 16, 2015

(HealthDay)—For hospitalized patients with diabetes, treatment with premixed insulin results in similar glycemic control but higher frequency of hypoglycemia compared with a basal-bolus regimen, according to a study published ...

Low-carb diet cuts tx effect of glucagon in hypoglycemia

November 7, 2016

(HealthDay)—For patients with type 1 diabetes, a low-carbohydrate diet (LCD) results in lower incremental rises in plasma glucose (PG) after mild hypoglycemia compared with an isocaloric high-carbohydrate diet (HCD), according ...

Recommended for you

Many diabetes patients produce some insulin

June 22, 2017

Some insulin is still produced in almost half of patients that have had type 1 diabetes for more than ten years. The study conducted by researchers at Uppsala University in Sweden has now been published online by the medical ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.